Previous 10 | Next 10 |
home / stock / cphrf / cphrf news
Cipher Pharmaceuticals Announces Normal Course Issuer Bid Canada NewsWire OAKVILLE, ON, Aug. 12, 2020 OAKVILLE, ON , Aug. 12, 2020 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (" Cipher " or the " Company ") announced today that it has filed, and the Toronto Stock Excha...
Cipher Pharmaceuticals ( OTC:CPHRF ) : Q2 GAAP EPS of $0.02 misses by $0.05 . More news on: Cipher Pharmaceuticals Inc., Earnings news and commentary, , Read more ...
Cipher Pharmaceuticals Schedules Q2 2020 Earnings Release and Conference Call Canada NewsWire OAKVILLE, ON, July 27, 2020 OAKVILLE, ON , July 27, 2020 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (" Cipher " or "the Company ") today announced it will release ...
Cipher Pharmaceuticals Appoints New Chief Financial Officer Canada NewsWire OAKVILLE, ON, July 2, 2020 OAKVILLE, ON , July 2, 2020 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (" Cipher " or " the Company ") is pleased to announce that it has appointed seasoned Financia...
Cipher Pharmaceuticals Inc. (CPHRF) Q1 2020 Earnings Conference Call May 08, 2020 08:30 AM ET Company Participants Craig Mull - Interim Chief Executive Officer Conference Call Participants Doug Loe - Echelon Wealth Partners Prasath Pandurangan - Bloom Burton Presentation ...
Cipher Pharmaceuticals ( OTC:CPHRF ): Q1 GAAP EPS of $0.10 beats by $0.05 . Revenue of $5.9M (+15.7% Y/Y) beats by $1.06M . Press Release More news on: Cipher Pharmaceuticals Inc., Earnings news and commentary, ,
Cipher Pharmaceuticals Reports First Quarter 2020 Financial Results Canada NewsWire OAKVILLE, ON, May 7, 2020 Earnings per common share increases to $0.10 ( $0.13 in Canadian Dollars 1 ) OAKVILLE, ON , May 7, 2020 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) (" ...
Cipher Pharmaceuticals Schedules Q1 2020 Earnings Release and Conference Call Canada NewsWire OAKVILLE, ON, April 27, 2020 OAKVILLE, ON , April 27, 2020 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) (" Cipher " or "the Company ") today announced it will release its Q1 20...
Cipher Pharmaceuticals Receives Positive Ruling on Binding Arbitration with Upsher-Smith Laboratories Canada NewsWire OAKVILLE, ON, April 20, 2020 OAKVILLE, ON , April 20, 2020 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) (" Cipher " or " the Company ") today announ...
Cipher Pharmaceuticals Inc. (CPHRF) Q4 2019 Earnings Conference Call March 26, 2020, 08:30 AM ET Company Participants Craig Mull - Interim CEO Nadine Jutlah - Interim CFO Conference Call Participants Andre Uddin - Mackie Research Capital Doug Loe - Echelon Wealth Partners ...
News, Short Squeeze, Breakout and More Instantly...
Companhia Siderurgica Paulista Nova Cosipa Company Name:
CPHRF Stock Symbol:
OTCMKTS Market:
Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders Canada NewsWire MISSISSAUGA, ON , June 14, 2024 /CNW/ - Cipher Pharmaceuticals Inc . (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the "Company ") today announced that i...
Cipher Pharmaceuticals Reports First Quarter 2024 Results Canada NewsWire (All figures are presented in U.S. Dollars) Adjusted EBITDA in Q1 2024 was $3.6 million , an increase of 12.5% over Q1 2023 Epuris sales volumes grew 7.2% in the quarter over Q1 2023, c...
Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call Canada NewsWire MISSISSAUGA, ON , May 3, 2024 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the " Company ") today announced that it will release ...